Država: Velika Britanija
Jezik: engleski
Izvor: HMA (Heads of Medicines Agencies)
enrofloxacin 50 mg/ml
Pfizer Limited
QM01AC06
Solution for injection
meloxicam
Cats, Cattle, Dogs, Pigs
2011-12-21
Issued: February 2012 AN: 01748/2010 Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Reneval 50 mg/ml Solution for Injection for cattle, pigs, dogs and cats. Reneval (DK) Reneval vet. 50 mg/ml Solution for Injection for cattle, pigs, dogs and cats. (FI, SE) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 ml of solution contains: Active substance Enrofloxacin 50.0 mg Excipients n-Butanol 30.0 mg For full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for injection. Clear light yellow solution free from particulate matter. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, Pigs, Dogs and Cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Cattle: Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. _pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and _ salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia), where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice. Issued: February 2012 AN: 01748/2010 Page 2 of 8 Pigs: Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. _pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-_ _septicaemia and _salmonellosis) and multifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal orga Pročitajte cijeli dokument